vHospital
Antiparasitic

Mebendazole: Mechanism of Action

Mebendazole is an antiparasitic medication used to treat intestinal worms, tissue parasites, or ectoparasitic infections.

MechanismInteractionsEvidenceClinical Studies

Benzimidazole antiparasitics bind to parasite β-tubulin, disrupting microtubule assembly and blocking intracellular glucose transport.

How It Works

Albendazole and mebendazole are benzimidazole antiparasitic agents that selectively bind to β-tubulin in helminth parasites, preventing polymerisation into microtubules. Disruption of microtubule-dependent processes impairs: intracellular transport of secretory granules, glucose uptake via inhibition of cytoskeletal GLUT anchoring, and mitotic spindle formation. The result is glycogen depletion, inhibition of secretory processes, and parasite death. Selectivity for parasite vs mammalian tubulin is exploited therapeutically. Albendazole sulphoxide (active metabolite) has superior tissue penetration enabling treatment of larval/tissue-stage parasites.

Receptor / Target Profile

Pharmacokinetics

Onset of Action

Intestinal helminths (single dose): egg output halted within 24 hours; parasite expulsion 2–5 days. Tissue stages (echinococcosis): weeks to months of treatment required

Half-Life (t½)

Albendazole sulphoxide (active): 8–12 hours. Mebendazole: 2–9 hours (poorly absorbed; acts largely intraluminally)

Mebendazole: poor oral absorption (<10%) — effective for intestinal helminths via high intraluminal concentration. Albendazole: variable oral absorption, enhanced 5× with fatty meal; extensive first-pass to active sulphoxide; systemic distribution enables treatment of tissue stages. Albendazole sulphoxide penetrates blood-brain barrier (~40% of plasma levels) and hydatid cysts.

Conditions Treated with Mebendazole

Questions about your medication?

Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant medications.

Use AI Symptom Checker →